ELIGARD Drug Patent Profile
✉ Email this page to a colleague
When do Eligard patents expire, and what generic alternatives are available?
Eligard is a drug marketed by Tolmar and is included in four NDAs. There are three patents protecting this drug.
The generic ingredient in ELIGARD is leuprolide acetate. There are twenty-two drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the leuprolide acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Eligard
A generic version of ELIGARD was approved as leuprolide acetate by SANDOZ on August 4th, 1998.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ELIGARD?
- What are the global sales for ELIGARD?
- What is Average Wholesale Price for ELIGARD?
Summary for ELIGARD
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 4 |
| Drug Prices: | Drug price information for ELIGARD |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ELIGARD |
| What excipients (inactive ingredients) are in ELIGARD? | ELIGARD excipients list |
| DailyMed Link: | ELIGARD at DailyMed |
Recent Clinical Trials for ELIGARD
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| TOLMAR PHARMACEUTIQUES CANADA, INC. | PHASE2 |
| Ontario Clinical Oncology Group (OCOG) - McMaster University | PHASE2 |
| Ontario Clinical Oncology Group (OCOG) | PHASE2 |
US Patents and Regulatory Information for ELIGARD
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tolmar | ELIGARD KIT | leuprolide acetate | POWDER;SUBCUTANEOUS | 021343-001 | Jan 23, 2002 | RX | Yes | Yes | 12,397,120 | ⤷ Get Started Free | ⤷ Get Started Free | ||||
| Tolmar | ELIGARD KIT | leuprolide acetate | POWDER;SUBCUTANEOUS | 021488-001 | Feb 13, 2003 | RX | Yes | Yes | 12,397,120 | ⤷ Get Started Free | ⤷ Get Started Free | ||||
| Tolmar | ELIGARD KIT | leuprolide acetate | POWDER;SUBCUTANEOUS | 021379-001 | Jul 24, 2002 | RX | Yes | Yes | 12,397,120 | ⤷ Get Started Free | ⤷ Get Started Free | ||||
| Tolmar | ELIGARD KIT | leuprolide acetate | POWDER;SUBCUTANEOUS | 021731-001 | Dec 14, 2004 | RX | Yes | Yes | 11,771,841 | ⤷ Get Started Free | Y | Y | ⤷ Get Started Free | ||
| Tolmar | ELIGARD KIT | leuprolide acetate | POWDER;SUBCUTANEOUS | 021488-001 | Feb 13, 2003 | RX | Yes | Yes | 11,771,841 | ⤷ Get Started Free | Y | Y | ⤷ Get Started Free | ||
| Tolmar | ELIGARD KIT | leuprolide acetate | POWDER;SUBCUTANEOUS | 021343-001 | Jan 23, 2002 | RX | Yes | Yes | 11,931,559 | ⤷ Get Started Free | Y | ⤷ Get Started Free | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
